Page 71 - Revista Argentina de Transfusión 1 - 2020

50. Kerkhoffs JLH, Eikenboom JC, Schipperus MS, van Wordragen- 53. Josephson CD, Castillejo MI, Grima K, Hillyer CD. ABO-mis-
Vlaswinkel RJ, Brand R, Harvey MS, et al. A multicenter matched platelet transfusions: Strategies to mitigate patient
randomized study of the efficacy of transfusions with platelets exposure to naturally occurring hemolytic antibodies. Transfu-
stored in platelet additive solution II versus plasma. Blood. sion and Apheresis Science. 2010 Feb;42(1):83–8.
2006 Nov 1;108(9):3210–5. 54. Win N, Chapman CE, Bowles KM, Green A, Bradley S,
51. van Hout FMA, van der Meer PF, Wiersum-Osselton JC, Edmondson D, et al. How much residual plasma may cause
Middelburg RA, Schipperus MR, van der Bom JG, et al. Transfu- TRALI? Transfusion Medicine. 2008 Oct;18(5):276–80.
sion reactions after transfusion of platelets stored in PAS-B, 55. Dumont LJ, Wood TA, Housman M, Herschel L, Brantigan B,
PAS-C, or plasma: a nationwide comparison. Transfusion. 2018 Heber C, et al. Bacterial growth kinetics in ACD-A apheresis
Apr 1;58(4):1021–7. platelets: Comparison of plasma and PAS III storage. Transfu-
52. Surowiecka M, Zantek N, Morgan S, Cohn CS, Dangerfield R. sion. 2011 May;51(5):1079–85.
Anti-A and anti-B titers in group O platelet units are reduced in
PAS C versus conventional plasma units. Vol. 54, Transfusion.
2014. p. 255–6.

Soluciones aditivas para plaquetas Vol. XLVI / N° 1 / 2020 Asociación Argentina Pág. 65
Págs. 57 / 65 de Hemoterapia,
Inmunohematología
y Terapia Celular